KAITLIN ZIEDONIS: Open Payments
NPI 1003402363 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 17 payments from 8 companies in 2025. Trend: 2023 $771 · 2024 $313 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $161 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 5 | $62 |
| Edwards Lifesciences Corporation | 1 | $40 |
| Abbott Laboratories | 2 | $38 |
| Medtronic, Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| BridgeBio Pharma, Inc. | 1 | $21 |
| Kestra Medical Technology Services, Inc. | 1 | $16 |
Products named: Wegovy, LifeVest, SAPIEN 3 Ultra RESILIA, MITRACLIP, LINQ II, LEQVIO, Attruby, Assure WCD.
Industry payments across IN — which companies pay providers there.
